Definitive Contract 75N93022C00014

The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a 10-year, $21,887,522 cost-plus-fixed-fee contract to PPD Development LP, a global contract research organization, to provide clinical site monitoring services for a variety of NIAID-funded clinical research programs, trials, and studies. The contract does not have a set-aside designation. Through this contract, PPD will be responsible for monitoring adherence to regulations and quality standards at clinical research sites, developing training programs, managing data systems, coordinating with other research support contractors, innovating risk-based monitoring methods, and implementing quality assurance plans. This contract is part of NIAID's broader clinical trial support efforts, which include several other major indefinite delivery contract vehicles with PPD, such as the $346 million Early Phase Clinical Trial Units IDC and the $545 million Comprehensive and Rapid Response contract.